Some probiotics have shown efficacy for patients with irritable bowel syndrome (IBS). The aim of this study was to investigate the symptomatic effect of L. plantarum MF1298 in subjects with IBS in a randomized double blind placebo-controlled crossover trial. Thirteen of 16 participants preferred placebo to L. plantarum MF1298 treatment. This trial shows for the first time an unfavorable effect on symptoms in subjects with IBS after intake of a potential probiotic.
Bonnie - it just shows that probiotics are not "one size fits all." This is yet another reason why I do not advocate self-supplementing.
Friday, April 02, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment